SCHEMBL5509863

SCHEMBL5509863

C=CCCC1=CCC(=S)C(N)=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isopropyl Alcohol SCHEMBL8624603 0.62 FAAH (0.30)
SCHEMBL7029065 0.62
Isopropyl Alcohol SCHEMBL8622993 0.60
SCHEMBL21742187 0.57
SCHEMBL29080413 0.53 TLR8 (0.32)
SCHEMBL16682341 0.53 GFER (0.59)
SCHEMBL8678477 0.52 USP2 (0.30)
SCHEMBL6751719 0.52 ALDH1A1 (0.44)
SCHEMBL28107459 0.52 TSHR (0.35)
SCHEMBL27482271 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7173059-B2 Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same AGOURON PHARMACEUTICALS, INC. (US) 2007-02-06 US disclosed
EP-1633704-A2 INTERMEDIATES USEFUL IN THE SYNTHESIS OF HIV-PROTEASE INHIBITORS AND METHODS FOR PREPARING THE SAME PFIZER INC. (US) 2006-03-15 EP disclosed
US-20050250949-A1 Intermediates useful in the synthesis of HIV-protease inhibitors and methods for preparing the same AGOURON PHARMACEUTICALS INC. 2005-11-10 US disclosed
WO-2004099129-A2 INTERMEDIATES USEFUL IN THE SYNTHESIS OF HIV-PROTEASE INHIBITORS AND METHODS FOR PREPARING THE SAME PFIZER INC. (US) 2004-11-18 WO disclosed